Key facts
- This page summarizes Jodi Devlin's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2025, 17:37.
Jodi Devlin - 18 Feb 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)
- Reporting relationship
- Chief of Clinical Operations
- Issuer ticker
- TLSI
- Reported as of
- 18 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Feb 2025, 17:37:35 UTC
- Prior SEC filing
- 29 Jan 2025
- Next SEC filing
- 21 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sean Murphy, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jodi Devlin filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 19 Feb 2025.
Change
- Previous filing in this sequence was filed on 29 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,272
- Change %
- +19%
- Price
- $0.000000
- Shares after
- 33,397
- Date
- 18 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.